Skip to main content
RESMED INC logo

RESMED INC — Investor Relations & Filings

Ticker · RMD LEI · 254900O2VD7IQ5OGI615 ASX Manufacturing
Open in API
Filings indexed 1,641 across all filing types
Latest filing 2025-09-02 Director's Dealing
Country AU Australia
Listing ASX RMD

About RESMED INC

https://www.resmed.com

ResMed Inc. is a global leader in the development, manufacturing, and distribution of medical devices and cloud-based software solutions for the management of sleep-disordered breathing, chronic obstructive pulmonary disease, and other respiratory conditions. The company’s primary product portfolio includes continuous positive airway pressure (CPAP) devices, bilevel machines, and a variety of masks and accessories designed to improve patient adherence and comfort. ResMed distinguishes itself through its focus on digital health, offering integrated software platforms that enable remote patient monitoring and data-driven clinical insights for healthcare providers. Additionally, the company provides software-as-a-service (SaaS) solutions to support out-of-hospital care settings, including home health, hospice, and skilled nursing facilities, aiming to improve patient outcomes and reduce overall healthcare costs.

Recent filings

Filing Released Lang Actions
Initial statement of beneficial ownership of securities 3 pages 143.5KB
Director's Dealing Classification · 100% confidence The document is a SEC Form 3, which is an Initial Statement of Beneficial Ownership of Securities filed pursuant to Section 16(a) of the Securities Exchange Act of 1934. It reports the beneficial ownership of securities by a company insider (in this case, a director/officer). The document includes details about the reporting person, the date of the event, and the securities owned (none in this case). It also contains a Power of Attorney granting authority to file such forms. This type of filing is a notification of insider share ownership and transactions by directors or officers, which corresponds to the category Director's Dealing (DIRS). The document is not a financial report, earnings release, or regulatory announcement but a specific insider transaction report.
2025-09-02 English
Statement of changes in beneficial ownership 1 page
Director's Dealing Classification · 100% confidence The document is a SEC Form 4 filing, which is a statement of changes in beneficial ownership of securities by company insiders such as officers, directors, or significant shareholders. It details transactions in the company's stock by an officer (Chief Product Officer) including dates, amounts, and nature of ownership changes. This type of filing is specifically related to insider trading disclosures and personal share transactions by company directors and executives. It is not a financial report, earnings release, or any other type of corporate report. Therefore, it fits the category of Director's Dealing (DIRS). The document length and content confirm it is the actual Form 4 filing, not just an announcement or certification.
2025-08-26 English
Statement of changes in beneficial ownership 1 page
Director's Dealing Classification · 100% confidence The document is a SEC Form 4 filing, which is a statement of changes in beneficial ownership of securities by company insiders such as directors and officers. It reports transactions in the company's shares by insiders, including acquisitions and dispositions. This type of filing is specifically related to insider trading disclosures and is categorized as Director's Dealing (DIRS). The document includes detailed tables of securities acquired or disposed of by Michael J. Farrell, the CEO, confirming it is a Director's Dealing report rather than a general financial report or announcement.
2025-08-26 English
Statement of changes in beneficial ownership 1 page
Director's Dealing Classification · 100% confidence The document is a SEC Form 4 filing, which is a statement of changes in beneficial ownership of company securities by insiders such as officers, directors, or significant shareholders. It details transactions in the company's shares by Michael J. Rider, the Global General Counsel of ResMed Inc. The form includes transaction dates, types, amounts, and ownership details. This type of filing is specifically used to report insider trades and changes in ownership by company insiders. It is not an earnings release, annual report, or any other financial or management report. Therefore, it fits the category of Director's Dealing (DIRS). The document length and content confirm it is the actual Form 4 filing, not just an announcement or certification, so the classification is confident.
2025-08-26 English
Statement of changes in beneficial ownership 2 pages 13.2KB
Director's Dealing Classification · 100% confidence The document is a Form 4 filed with the United States Securities and Exchange Commission (SEC). Form 4 is used to report changes in beneficial ownership of company securities by directors, officers, or significant shareholders. The document includes detailed tables of securities acquired or disposed of, transaction dates, prices, and ownership forms. It is not a financial report, earnings release, or management discussion, but specifically a report of insider transactions by a company director. Therefore, it fits the category of Director's Dealing (DIRS). The document length and content confirm it is the actual filing, not just an announcement or certification.
2025-08-26 English
Statement of changes in beneficial ownership 1 page
Director's Dealing Classification · 100% confidence The document is a SEC Form 4 filing, which is a statement of changes in beneficial ownership of company securities by insiders such as officers, directors, or significant shareholders. It details transactions in the company's stock by Brett Sandercock, the Chief Financial Officer of ResMed Inc. This type of filing is specifically used to report insider trades and changes in ownership by company insiders. The presence of transaction dates, security titles, and ownership details confirms it is a Director's Dealing report. It is not an earnings release, annual report, or any other type of financial or regulatory report. Therefore, the correct classification is Director's Dealing (DIRS).
2025-08-26 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.